Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Longevity Research Compounds/ SS-31 (Elamipretide)
In stock
SS-31 (Elamipretide)

SS-31 (Elamipretide)

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

SS-31 (Elamipretide) is a synthetic tetrapeptide aromatic-cationic compound with the sequence D-Arg-Dmt-Lys-Phe-NH₂ (Dmt = 2′,6′-dimethyltyrosine), designed to target and stabilise cardiolipin on the inner mitochondrial membrane; CAS 736992-21-5; molecular weight 639.8 g/mol; studied in models of mitochondrial dysfunction, oxidative stress attenuation, and neuroprotection. For laboratory research use only; not for human or veterinary use.

Mitochondria power nearly every cell, and when their inner membranes falter, so does the tissue around them. SS-31, known generically as elamipretide, is a synthetic, cell-permeable tetrapeptide designed to concentrate in the inner mitochondrial membrane. It has become one of the most closely studied mitochondria-targeted peptides in bioenergetics research, and recently reached a regulatory milestone as the first cardiolipin-directed mitochondrial therapeutic to gain approval (Shirley et al., 2026).

A peptide that homes to the mitochondrion. Elamipretide's alternating aromatic-cationic structure allows it to cross cell membranes and associate selectively with cardiolipin, a signature phospholipid of the inner mitochondrial membrane. By binding cardiolipin, it is proposed to stabilize cristae architecture and support electron transport chain organization, thereby improving bioenergetic efficiency and reducing reactive oxygen species generation (Sabbah et al., 2025; Tung et al., 2025). This mechanism makes SS-31 a precise tool for interrogating mitochondrial contributions to cellular stress.

What the research explores. Investigations span multiple model systems:

  • Mitochondrial bioenergetics — reviews detail how elamipretide engages cardiolipin to preserve membrane potential and ATP synthesis (Tung et al., 2025; Sabbah et al., 2025).
  • Aging and cardiac/skeletal muscle — preclinical work reports improvements in cardiac and skeletal muscle parameters in aged models (Mitchell et al., 2025).
  • Neural and cerebrovascular models — studies examine SS-31 in the context of cerebral microhemorrhages and aging-related mitochondrial dysfunction (Patai et al., 2025).
  • Reproductive and cellular protection — work explores mitochondrial-targeted effects during in vitro porcine embryo production (Nguyen et al., 2025).

These findings arise from in vitro, animal, and clinical research and describe biological activity rather than human safety or efficacy outcomes outside the approved indication. Full citations are listed under the Scientific References tab.

Physicochemical profile. CAS 736992-21-5 · Molecular formula C₃₂H₄₉N₉O₅ · Molecular weight 639.8 g/mol · Sequence D-Arg-Dmt-Lys-Phe-NH₂ · Appearance: white lyophilized powder · Soluble in water.

Specification & quality. Each individually sealed vial contains 10 mg of SS-31 (elamipretide) as a white lyophilized powder at ≥99% purity by HPLC. Every batch is third-party tested, with a Certificate of Analysis (COA) available. Store at −20 °C, protected from light and moisture.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number736992-21-5
Molecular formulaC₃₂H₄₉N₉O₅
Molecular weight639.8
SequenceD-Arg-Dmt-Lys-Phe-NH₂
Purity≥99% (HPLC)
Physical formWhite lyophilized powder
Quantity10mg/vial
SolubilitySoluble in water
StorageStore at -20°C, protect from light
Shelf life24 months from manufacture date
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Shirley M. Elamipretide: First Approval. Drugs. 2026. PMID: 41335372. doi:10.1007/s40265-025-02269-8. PubMed 02 Jacob N, Schecter D, Marshall M et al.. Elamipretide in the Management of Barth Syndrome: Current Evidence and a Case Report. Mol Genet Metab. 2025. PMID: 40816230. doi:10.1016/j.ymgme.2025.109220. PubMed 03 Sabbah HN, Alder NN, Sparagna GC et al.. Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. Biomed Pharmacother. 2025. PMID: 40294492. doi:10.1016/j.biopha.2025.118056. PubMed 04 Tung C, Varzideh F, Farroni E et al.. Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential. Int J Mol Sci. 2025. PMID: 39940712. doi:10.3390/ijms26030944. PubMed 05 Song Z, Ban Z, Zhao H et al.. Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury. Neurochem Int. 2026. PMID: 42082001. doi:10.1016/j.neuint.2026.106171. PubMed 06 Xie M, Weng J, Li C et al.. Mechanisms of Anti-Oxidants, N-Acetylcysteine and Elamipretide (SS-31), on Ozone-Induced Airway Hyperresponsiveness and Mucus Hypersecretion. Lung. 2026. PMID: 41801306. doi:10.1007/s00408-026-00875-1. PubMed 07 . Elamipretide Hydrochloride. Am J Health Syst Pharm. 2026. PMID: 41206662. doi:10.1093/ajhp/zxaf303. PubMed 08 Schauer A, Jahn D, Vahle B et al.. Mitochondrial Targeting by Elamipretide Improves Myocardial Bioenergetics Without Translating into Functional Benefits in HFpEF. Int J Mol Sci. 2026. PMID: 41596703. doi:10.3390/ijms27021060. PubMed 09 Zhao C, Zhuang X, Gao J. Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approval. Drug Discov Ther. 2026. PMID: 41260682. doi:10.5582/ddt.2025.01111. PubMed 10 Vieira Neto E, Wang M, Szuminsky AJ et al.. Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein-Deficient Mice and Human Fibroblasts. J Inherit Metab Dis. 2026. PMID: 41500837. doi:10.1002/jimd.70132. PubMed 11 Nguyen ST, Otoi T, Namula Z et al.. Mitochondrial-Targeted Protective Potential of Elamipretide for the In Vitro Production of Porcine Embryos. Animals (Basel). 2025. PMID: 40941292. doi:10.3390/ani15172497. PubMed 12 Najafi A, Sharifi SD, Farhadi R et al.. Elamipretide enhances post-thaw rooster sperm quality by mitigating oxidative stress and optimizing mitochondrial function during cryopreservation. Sci Rep. 2025. PMID: 40604246. doi:10.1038/s41598-025-09943-7. PubMed 13 Patai R, Patel K, Csik B et al.. Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening. Geroscience. 2025. PMID: 40169521. doi:10.1007/s11357-025-01634-5. PubMed 14 Mitchell W, Pharaoh G, Tyshkovskiy A et al.. The Mitochondria-Targeted Peptide Therapeutic Elamipretide Improves Cardiac and Skeletal Muscle Function During Aging Without Detectable Changes in Tissue Epigenetic or Transcriptomic Age. Aging Cell. 2025. PMID: 40080911. doi:10.1111/acel.70026. PubMed 15 Bulbul O, Mammadov R, Suleyman B et al.. Effect of elamipretide and methylprednisolone treatment on optic nerve, retina and brain damage in a methanol poisoning model: biochemical and histopathological evaluation. Cutan Ocul Toxicol. 2025. PMID: 39601106. doi:10.1080/15569527.2024.2430241. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

SS-31, also called Elamipretide, is a synthetic mitochondria-targeting tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively associates with cardiolipin on the inner mitochondrial membrane. It is a widely studied tool in mitochondrial bioenergetics research. Condor Research supplies it as a 10 mg lyophilized vial at ≥99% HPLC purity, strictly for in-vitro laboratory research use only.

SS-31 is a four-residue peptide that binds cardiolipin and acts directly at the inner mitochondrial membrane, while MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial genome that signals more broadly in metabolic regulation. Both are mitochondrial research tools but act at different levels. Each is a separate ≥99% HPLC, research-use-only reference compound.

SS-31 (Elamipretide) is a cardiolipin-binding peptide that localizes to the inner mitochondrial membrane, whereas NAD+ is a fundamental redox coenzyme central to cellular energy metabolism. One is a membrane-targeting reference peptide, the other a metabolic cofactor; they are studied for complementary but distinct aspects of bioenergetics. Both are supplied strictly as research-use-only reference materials.

SS-31 is a mitochondria-targeting tetrapeptide that associates with cardiolipin, while AICAR is a small-molecule activator of AMP-activated protein kinase (AMPK), the cell's energy sensor. One targets the mitochondrial membrane directly; the other acts on an upstream signalling enzyme. Researchers select between them by mechanism. Both are offered as ≥99% HPLC, research-use-only reference compounds.

SS-31 is selected when the research target is specifically cardiolipin and the inner mitochondrial membrane, a mechanism distinct from genome-encoded peptides like MOTS-c or metabolic activators like AICAR. Its small, defined tetrapeptide structure makes it a focused reference tool. As with all catalog items, it is for in-vitro research only, with no human or veterinary use.

SS-31 (Elamipretide) is a mitochondria-targeting tetrapeptide that acts at cardiolipin, whereas Pinealon is a short Glu-Asp-Arg tripeptide bioregulator studied in neuroprotection and longevity contexts. They appear together under neuroprotective research themes but address different molecular targets. Condor Research offers both as separate ≥99% HPLC, research-use-only reference materials for laboratory study.

Yes. The non-standard residues — D-arginine and 2,6-dimethyltyrosine (Dmt) — and the full amidated sequence (D-Arg-Dmt-Lys-Phe-NH2, CAS 736992-21-5) are verified for each lot by an independent third-party laboratory using HPLC for purity and mass spectrometry for identity. Results are documented on the batch-specific Certificate of Analysis available on request.

Yes. SS-31 is supplied strictly for laboratory research use only (in vitro). It is not a medicine, food, supplement, cosmetic, or medical device, and is not for human or veterinary use, administration, or consumption. Condor Research provides no dosing, protocols, or human-use guidance. Purchase is limited to qualified professionals and institutions aged 18 or over.

Yes. Each SS-31 lot is tested by an independent third-party laboratory by HPLC for identity and purity, with mass spectrometry confirmation, and ships against a batch-specific Certificate of Analysis verifying ≥99% purity. To request the COA for the current lot before ordering, contact info@condorresearch.com.

For analytical laboratory preparation only, SS-31 is water-soluble and can be reconstituted with a sterile aqueous diluent; the chosen volume sets the working concentration. Store the sealed lyophilized vial at -20°C, protected from light, with a 24-month shelf life from manufacture. This is laboratory handling information, not guidance for any human or animal use.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).
4.7
39 verified reviews
5
77%
4
15%
3
5%
2
3%
1
0%
Apr 2026
Exactly what research needs

No marketing fluff — just characterised material with paperwork. The data sheet and CAS matched our records precisely.

J. Meijer · Biotech R&D · NL Verified purchase
Mar 2026
High purity, clear labelling

Lyophilised cake was uniform and dissolved fully. Would appreciate a digital COA portal, but the PDF on request worked fine.

Dr. A. Bianchi · University · IT Verified purchase
Mar 2026
Trustworthy supplier

Identity by MS confirmed in our facility. Communication around storage and handling was precise and professional.

K. Wójcik · Research group · PL Verified purchase
Feb 2026
Reference-grade consistency

Reconstitution was clean with no visible particulates. The lot-specific COA matched the assay we ran in-house — purity is exactly as stated.

Dr. M. Hartmann · Research lab · DE Verified purchase
Jan 2026
COA matched our own HPLC

We verify every incoming compound by HPLC; this batch came back within tolerance of the certificate. Dispatch from the EU warehouse was quick.

L. Fischer · University group · AT Verified purchase

Related compounds